MedTrace Logo

A Comparative Study of the SoftTouch Non-Invasive Finger-Mounted Device

NCT00712361 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2020-01-28

No results posted yet for this study

Summary

1. Aim:

SoftTouch is a non-invasive device intending for use in the temporarily quantitative measurement of peripheral blood biomarkers. The aim of the clinical trial is to study the accuracy of the SoftTouch device compared with registered (FDA-approved) invasive and non-invasive devices.
2. Hypothesis:

Human physiological biomarkers may be measured from the color distribution of the internal or external (skin) tissue. The technology of the SoftTouch finger-mounted device is based on the color distribution of the peripheral blood tissue, which enables the measurement of certain biomarkers and vital signs under consideration.

Conditions

  • Accuracy of the SofTouch Device Measuring Blood Glucose and Other Parameters

Interventions

DEVICE

Non Invasive peripheral blood screening (Cnoga Medical Ltd.,SofTouch,OnlyTouch, CM-CL-R-007, CMC 07015922,HT 4502, HTA 4502)

Non Invasive screening of various independent peripheral blood parameters: Glucose, hemoglobin, Hematocrit, blood pressure, pulse, SpO2, CO2, pH.

Sponsors & Collaborators

  • Carmel Medical Center

    collaborator OTHER

  • Cnoga Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Eli Zuckerman, Prof. · Carmel Medical Center - Head of Liver Unit

  • Yosef Segman, PhD · Cnoga Medical Ltd.

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00712361 on ClinicalTrials.gov